0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Viral Inactivation Kits Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-8W8292
Home | Market Reports | Health| Medical Devices & Equipment
Global Viral Inactivation Kits Market Insights Forecast to 2028
BUY CHAPTERS

Global Viral Inactivation Kits Market Research Report 2025

Code: QYRE-Auto-8W8292
Report
July 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Viral Inactivation Kits Market

The global market for Viral Inactivation Kits was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Viral Inactivation Kits is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Viral Inactivation Kits is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Viral Inactivation Kits include Merck KGAA, Danaher Corporation, Texcell Inc, Sartorius AG, Wuxi Pharmatech (Cayman) Inc, Viral Inactivated Plasma Systems SA, Clean Cells Inc, Parker Hannifin Corporation, SGS SA, Charles River Laboratories International Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Viral Inactivation Kits, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Inactivation Kits.
The Viral Inactivation Kits market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Viral Inactivation Kits market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Viral Inactivation Kits manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Viral Inactivation Kits Market Report

Report Metric Details
Report Name Viral Inactivation Kits Market
Segment by Type
  • Disposable Use
  • Reusable Use
Segment by Application
  • Hospital
  • Scientific Research
  • Diagnostic Center
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck KGAA, Danaher Corporation, Texcell Inc, Sartorius AG, Wuxi Pharmatech (Cayman) Inc, Viral Inactivated Plasma Systems SA, Clean Cells Inc, Parker Hannifin Corporation, SGS SA, Charles River Laboratories International Inc, Rad Source Technologies Inc, HiMedia Laboratories Pvt Ltd
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Viral Inactivation Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Viral Inactivation Kits in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Viral Inactivation Kits Market report?

Ans: The main players in the Viral Inactivation Kits Market are Merck KGAA, Danaher Corporation, Texcell Inc, Sartorius AG, Wuxi Pharmatech (Cayman) Inc, Viral Inactivated Plasma Systems SA, Clean Cells Inc, Parker Hannifin Corporation, SGS SA, Charles River Laboratories International Inc, Rad Source Technologies Inc, HiMedia Laboratories Pvt Ltd

What are the Application segmentation covered in the Viral Inactivation Kits Market report?

Ans: The Applications covered in the Viral Inactivation Kits Market report are Hospital, Scientific Research, Diagnostic Center

What are the Type segmentation covered in the Viral Inactivation Kits Market report?

Ans: The Types covered in the Viral Inactivation Kits Market report are Disposable Use, Reusable Use

1 Viral Inactivation Kits Market Overview
1.1 Product Definition
1.2 Viral Inactivation Kits by Type
1.2.1 Global Viral Inactivation Kits Market Value Comparison by Type (2024 VS 2031)
1.2.2 Disposable Use
1.2.3 Reusable Use
1.3 Viral Inactivation Kits by Application
1.3.1 Global Viral Inactivation Kits Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Scientific Research
1.3.4 Diagnostic Center
1.4 Global Viral Inactivation Kits Market Size Estimates and Forecasts
1.4.1 Global Viral Inactivation Kits Revenue 2020-2031
1.4.2 Global Viral Inactivation Kits Sales 2020-2031
1.4.3 Global Viral Inactivation Kits Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Viral Inactivation Kits Market Competition by Manufacturers
2.1 Global Viral Inactivation Kits Sales Market Share by Manufacturers (2020-2025)
2.2 Global Viral Inactivation Kits Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Viral Inactivation Kits Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Viral Inactivation Kits, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Viral Inactivation Kits, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Viral Inactivation Kits, Product Type & Application
2.7 Global Key Manufacturers of Viral Inactivation Kits, Date of Enter into This Industry
2.8 Global Viral Inactivation Kits Market Competitive Situation and Trends
2.8.1 Global Viral Inactivation Kits Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Viral Inactivation Kits Players Market Share by Revenue
2.8.3 Global Viral Inactivation Kits Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Viral Inactivation Kits Market Scenario by Region
3.1 Global Viral Inactivation Kits Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Viral Inactivation Kits Sales by Region: 2020-2031
3.2.1 Global Viral Inactivation Kits Sales by Region: 2020-2025
3.2.2 Global Viral Inactivation Kits Sales by Region: 2026-2031
3.3 Global Viral Inactivation Kits Revenue by Region: 2020-2031
3.3.1 Global Viral Inactivation Kits Revenue by Region: 2020-2025
3.3.2 Global Viral Inactivation Kits Revenue by Region: 2026-2031
3.4 North America Viral Inactivation Kits Market Facts & Figures by Country
3.4.1 North America Viral Inactivation Kits Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Viral Inactivation Kits Sales by Country (2020-2031)
3.4.3 North America Viral Inactivation Kits Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Viral Inactivation Kits Market Facts & Figures by Country
3.5.1 Europe Viral Inactivation Kits Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Viral Inactivation Kits Sales by Country (2020-2031)
3.5.3 Europe Viral Inactivation Kits Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Viral Inactivation Kits Market Facts & Figures by Region
3.6.1 Asia Pacific Viral Inactivation Kits Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Viral Inactivation Kits Sales by Region (2020-2031)
3.6.3 Asia Pacific Viral Inactivation Kits Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Viral Inactivation Kits Market Facts & Figures by Country
3.7.1 Latin America Viral Inactivation Kits Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Viral Inactivation Kits Sales by Country (2020-2031)
3.7.3 Latin America Viral Inactivation Kits Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Viral Inactivation Kits Market Facts & Figures by Country
3.8.1 Middle East and Africa Viral Inactivation Kits Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Viral Inactivation Kits Sales by Country (2020-2031)
3.8.3 Middle East and Africa Viral Inactivation Kits Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Viral Inactivation Kits Sales by Type (2020-2031)
4.1.1 Global Viral Inactivation Kits Sales by Type (2020-2025)
4.1.2 Global Viral Inactivation Kits Sales by Type (2026-2031)
4.1.3 Global Viral Inactivation Kits Sales Market Share by Type (2020-2031)
4.2 Global Viral Inactivation Kits Revenue by Type (2020-2031)
4.2.1 Global Viral Inactivation Kits Revenue by Type (2020-2025)
4.2.2 Global Viral Inactivation Kits Revenue by Type (2026-2031)
4.2.3 Global Viral Inactivation Kits Revenue Market Share by Type (2020-2031)
4.3 Global Viral Inactivation Kits Price by Type (2020-2031)
5 Segment by Application
5.1 Global Viral Inactivation Kits Sales by Application (2020-2031)
5.1.1 Global Viral Inactivation Kits Sales by Application (2020-2025)
5.1.2 Global Viral Inactivation Kits Sales by Application (2026-2031)
5.1.3 Global Viral Inactivation Kits Sales Market Share by Application (2020-2031)
5.2 Global Viral Inactivation Kits Revenue by Application (2020-2031)
5.2.1 Global Viral Inactivation Kits Revenue by Application (2020-2025)
5.2.2 Global Viral Inactivation Kits Revenue by Application (2026-2031)
5.2.3 Global Viral Inactivation Kits Revenue Market Share by Application (2020-2031)
5.3 Global Viral Inactivation Kits Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck KGAA
6.1.1 Merck KGAA Company Information
6.1.2 Merck KGAA Description and Business Overview
6.1.3 Merck KGAA Viral Inactivation Kits Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck KGAA Viral Inactivation Kits Product Portfolio
6.1.5 Merck KGAA Recent Developments/Updates
6.2 Danaher Corporation
6.2.1 Danaher Corporation Company Information
6.2.2 Danaher Corporation Description and Business Overview
6.2.3 Danaher Corporation Viral Inactivation Kits Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Danaher Corporation Viral Inactivation Kits Product Portfolio
6.2.5 Danaher Corporation Recent Developments/Updates
6.3 Texcell Inc
6.3.1 Texcell Inc Company Information
6.3.2 Texcell Inc Description and Business Overview
6.3.3 Texcell Inc Viral Inactivation Kits Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Texcell Inc Viral Inactivation Kits Product Portfolio
6.3.5 Texcell Inc Recent Developments/Updates
6.4 Sartorius AG
6.4.1 Sartorius AG Company Information
6.4.2 Sartorius AG Description and Business Overview
6.4.3 Sartorius AG Viral Inactivation Kits Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sartorius AG Viral Inactivation Kits Product Portfolio
6.4.5 Sartorius AG Recent Developments/Updates
6.5 Wuxi Pharmatech (Cayman) Inc
6.5.1 Wuxi Pharmatech (Cayman) Inc Company Information
6.5.2 Wuxi Pharmatech (Cayman) Inc Description and Business Overview
6.5.3 Wuxi Pharmatech (Cayman) Inc Viral Inactivation Kits Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Wuxi Pharmatech (Cayman) Inc Viral Inactivation Kits Product Portfolio
6.5.5 Wuxi Pharmatech (Cayman) Inc Recent Developments/Updates
6.6 Viral Inactivated Plasma Systems SA
6.6.1 Viral Inactivated Plasma Systems SA Company Information
6.6.2 Viral Inactivated Plasma Systems SA Description and Business Overview
6.6.3 Viral Inactivated Plasma Systems SA Viral Inactivation Kits Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Viral Inactivated Plasma Systems SA Viral Inactivation Kits Product Portfolio
6.6.5 Viral Inactivated Plasma Systems SA Recent Developments/Updates
6.7 Clean Cells Inc
6.7.1 Clean Cells Inc Company Information
6.7.2 Clean Cells Inc Description and Business Overview
6.7.3 Clean Cells Inc Viral Inactivation Kits Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Clean Cells Inc Viral Inactivation Kits Product Portfolio
6.7.5 Clean Cells Inc Recent Developments/Updates
6.8 Parker Hannifin Corporation
6.8.1 Parker Hannifin Corporation Company Information
6.8.2 Parker Hannifin Corporation Description and Business Overview
6.8.3 Parker Hannifin Corporation Viral Inactivation Kits Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Parker Hannifin Corporation Viral Inactivation Kits Product Portfolio
6.8.5 Parker Hannifin Corporation Recent Developments/Updates
6.9 SGS SA
6.9.1 SGS SA Company Information
6.9.2 SGS SA Description and Business Overview
6.9.3 SGS SA Viral Inactivation Kits Sales, Revenue and Gross Margin (2020-2025)
6.9.4 SGS SA Viral Inactivation Kits Product Portfolio
6.9.5 SGS SA Recent Developments/Updates
6.10 Charles River Laboratories International Inc
6.10.1 Charles River Laboratories International Inc Company Information
6.10.2 Charles River Laboratories International Inc Description and Business Overview
6.10.3 Charles River Laboratories International Inc Viral Inactivation Kits Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Charles River Laboratories International Inc Viral Inactivation Kits Product Portfolio
6.10.5 Charles River Laboratories International Inc Recent Developments/Updates
6.11 Rad Source Technologies Inc
6.11.1 Rad Source Technologies Inc Company Information
6.11.2 Rad Source Technologies Inc Description and Business Overview
6.11.3 Rad Source Technologies Inc Viral Inactivation Kits Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Rad Source Technologies Inc Viral Inactivation Kits Product Portfolio
6.11.5 Rad Source Technologies Inc Recent Developments/Updates
6.12 HiMedia Laboratories Pvt Ltd
6.12.1 HiMedia Laboratories Pvt Ltd Company Information
6.12.2 HiMedia Laboratories Pvt Ltd Description and Business Overview
6.12.3 HiMedia Laboratories Pvt Ltd Viral Inactivation Kits Sales, Revenue and Gross Margin (2020-2025)
6.12.4 HiMedia Laboratories Pvt Ltd Viral Inactivation Kits Product Portfolio
6.12.5 HiMedia Laboratories Pvt Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Viral Inactivation Kits Industry Chain Analysis
7.2 Viral Inactivation Kits Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Viral Inactivation Kits Production Mode & Process Analysis
7.4 Viral Inactivation Kits Sales and Marketing
7.4.1 Viral Inactivation Kits Sales Channels
7.4.2 Viral Inactivation Kits Distributors
7.5 Viral Inactivation Kits Customer Analysis
8 Viral Inactivation Kits Market Dynamics
8.1 Viral Inactivation Kits Industry Trends
8.2 Viral Inactivation Kits Market Drivers
8.3 Viral Inactivation Kits Market Challenges
8.4 Viral Inactivation Kits Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Viral Inactivation Kits Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Viral Inactivation Kits Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Viral Inactivation Kits Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Viral Inactivation Kits Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Viral Inactivation Kits Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Viral Inactivation Kits Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Viral Inactivation Kits Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Viral Inactivation Kits Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Viral Inactivation Kits, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Viral Inactivation Kits, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Viral Inactivation Kits, Product Type & Application
 Table 12. Global Key Manufacturers of Viral Inactivation Kits, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Viral Inactivation Kits by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Inactivation Kits as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Viral Inactivation Kits Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Viral Inactivation Kits Sales by Region (2020-2025) & (K Units)
 Table 18. Global Viral Inactivation Kits Sales Market Share by Region (2020-2025)
 Table 19. Global Viral Inactivation Kits Sales by Region (2026-2031) & (K Units)
 Table 20. Global Viral Inactivation Kits Sales Market Share by Region (2026-2031)
 Table 21. Global Viral Inactivation Kits Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Viral Inactivation Kits Revenue Market Share by Region (2020-2025)
 Table 23. Global Viral Inactivation Kits Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Viral Inactivation Kits Revenue Market Share by Region (2026-2031)
 Table 25. North America Viral Inactivation Kits Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Viral Inactivation Kits Sales by Country (2020-2025) & (K Units)
 Table 27. North America Viral Inactivation Kits Sales by Country (2026-2031) & (K Units)
 Table 28. North America Viral Inactivation Kits Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Viral Inactivation Kits Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Viral Inactivation Kits Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Viral Inactivation Kits Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Viral Inactivation Kits Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Viral Inactivation Kits Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Viral Inactivation Kits Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Viral Inactivation Kits Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Viral Inactivation Kits Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Viral Inactivation Kits Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Viral Inactivation Kits Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Viral Inactivation Kits Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Viral Inactivation Kits Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Viral Inactivation Kits Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Viral Inactivation Kits Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Viral Inactivation Kits Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Viral Inactivation Kits Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Viral Inactivation Kits Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Viral Inactivation Kits Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Viral Inactivation Kits Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Viral Inactivation Kits Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Viral Inactivation Kits Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Viral Inactivation Kits Sales (K Units) by Type (2020-2025)
 Table 51. Global Viral Inactivation Kits Sales (K Units) by Type (2026-2031)
 Table 52. Global Viral Inactivation Kits Sales Market Share by Type (2020-2025)
 Table 53. Global Viral Inactivation Kits Sales Market Share by Type (2026-2031)
 Table 54. Global Viral Inactivation Kits Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Viral Inactivation Kits Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Viral Inactivation Kits Revenue Market Share by Type (2020-2025)
 Table 57. Global Viral Inactivation Kits Revenue Market Share by Type (2026-2031)
 Table 58. Global Viral Inactivation Kits Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Viral Inactivation Kits Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Viral Inactivation Kits Sales (K Units) by Application (2020-2025)
 Table 61. Global Viral Inactivation Kits Sales (K Units) by Application (2026-2031)
 Table 62. Global Viral Inactivation Kits Sales Market Share by Application (2020-2025)
 Table 63. Global Viral Inactivation Kits Sales Market Share by Application (2026-2031)
 Table 64. Global Viral Inactivation Kits Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Viral Inactivation Kits Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Viral Inactivation Kits Revenue Market Share by Application (2020-2025)
 Table 67. Global Viral Inactivation Kits Revenue Market Share by Application (2026-2031)
 Table 68. Global Viral Inactivation Kits Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Viral Inactivation Kits Price (US$/Unit) by Application (2026-2031)
 Table 70. Merck KGAA Company Information
 Table 71. Merck KGAA Description and Business Overview
 Table 72. Merck KGAA Viral Inactivation Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Merck KGAA Viral Inactivation Kits Product
 Table 74. Merck KGAA Recent Developments/Updates
 Table 75. Danaher Corporation Company Information
 Table 76. Danaher Corporation Description and Business Overview
 Table 77. Danaher Corporation Viral Inactivation Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Danaher Corporation Viral Inactivation Kits Product
 Table 79. Danaher Corporation Recent Developments/Updates
 Table 80. Texcell Inc Company Information
 Table 81. Texcell Inc Description and Business Overview
 Table 82. Texcell Inc Viral Inactivation Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Texcell Inc Viral Inactivation Kits Product
 Table 84. Texcell Inc Recent Developments/Updates
 Table 85. Sartorius AG Company Information
 Table 86. Sartorius AG Description and Business Overview
 Table 87. Sartorius AG Viral Inactivation Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Sartorius AG Viral Inactivation Kits Product
 Table 89. Sartorius AG Recent Developments/Updates
 Table 90. Wuxi Pharmatech (Cayman) Inc Company Information
 Table 91. Wuxi Pharmatech (Cayman) Inc Description and Business Overview
 Table 92. Wuxi Pharmatech (Cayman) Inc Viral Inactivation Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Wuxi Pharmatech (Cayman) Inc Viral Inactivation Kits Product
 Table 94. Wuxi Pharmatech (Cayman) Inc Recent Developments/Updates
 Table 95. Viral Inactivated Plasma Systems SA Company Information
 Table 96. Viral Inactivated Plasma Systems SA Description and Business Overview
 Table 97. Viral Inactivated Plasma Systems SA Viral Inactivation Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Viral Inactivated Plasma Systems SA Viral Inactivation Kits Product
 Table 99. Viral Inactivated Plasma Systems SA Recent Developments/Updates
 Table 100. Clean Cells Inc Company Information
 Table 101. Clean Cells Inc Description and Business Overview
 Table 102. Clean Cells Inc Viral Inactivation Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Clean Cells Inc Viral Inactivation Kits Product
 Table 104. Clean Cells Inc Recent Developments/Updates
 Table 105. Parker Hannifin Corporation Company Information
 Table 106. Parker Hannifin Corporation Description and Business Overview
 Table 107. Parker Hannifin Corporation Viral Inactivation Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Parker Hannifin Corporation Viral Inactivation Kits Product
 Table 109. Parker Hannifin Corporation Recent Developments/Updates
 Table 110. SGS SA Company Information
 Table 111. SGS SA Description and Business Overview
 Table 112. SGS SA Viral Inactivation Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. SGS SA Viral Inactivation Kits Product
 Table 114. SGS SA Recent Developments/Updates
 Table 115. Charles River Laboratories International Inc Company Information
 Table 116. Charles River Laboratories International Inc Description and Business Overview
 Table 117. Charles River Laboratories International Inc Viral Inactivation Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Charles River Laboratories International Inc Viral Inactivation Kits Product
 Table 119. Charles River Laboratories International Inc Recent Developments/Updates
 Table 120. Rad Source Technologies Inc Company Information
 Table 121. Rad Source Technologies Inc Description and Business Overview
 Table 122. Rad Source Technologies Inc Viral Inactivation Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Rad Source Technologies Inc Viral Inactivation Kits Product
 Table 124. Rad Source Technologies Inc Recent Developments/Updates
 Table 125. HiMedia Laboratories Pvt Ltd Company Information
 Table 126. HiMedia Laboratories Pvt Ltd Description and Business Overview
 Table 127. HiMedia Laboratories Pvt Ltd Viral Inactivation Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. HiMedia Laboratories Pvt Ltd Viral Inactivation Kits Product
 Table 129. HiMedia Laboratories Pvt Ltd Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Viral Inactivation Kits Distributors List
 Table 133. Viral Inactivation Kits Customers List
 Table 134. Viral Inactivation Kits Market Trends
 Table 135. Viral Inactivation Kits Market Drivers
 Table 136. Viral Inactivation Kits Market Challenges
 Table 137. Viral Inactivation Kits Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Viral Inactivation Kits
 Figure 2. Global Viral Inactivation Kits Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Viral Inactivation Kits Market Share by Type: 2024 & 2031
 Figure 4. Disposable Use Product Picture
 Figure 5. Reusable Use Product Picture
 Figure 6. Global Viral Inactivation Kits Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Viral Inactivation Kits Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Scientific Research
 Figure 10. Diagnostic Center
 Figure 11. Global Viral Inactivation Kits Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Viral Inactivation Kits Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Viral Inactivation Kits Sales (2020-2031) & (K Units)
 Figure 14. Global Viral Inactivation Kits Average Price (US$/Unit) & (2020-2031)
 Figure 15. Viral Inactivation Kits Report Years Considered
 Figure 16. Viral Inactivation Kits Sales Share by Manufacturers in 2024
 Figure 17. Global Viral Inactivation Kits Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Viral Inactivation Kits Players: Market Share by Revenue in Viral Inactivation Kits in 2024
 Figure 19. Viral Inactivation Kits Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Viral Inactivation Kits Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Viral Inactivation Kits Sales Market Share by Country (2020-2031)
 Figure 22. North America Viral Inactivation Kits Revenue Market Share by Country (2020-2031)
 Figure 23. United States Viral Inactivation Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Viral Inactivation Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Viral Inactivation Kits Sales Market Share by Country (2020-2031)
 Figure 26. Europe Viral Inactivation Kits Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Viral Inactivation Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Viral Inactivation Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Viral Inactivation Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Viral Inactivation Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Viral Inactivation Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Viral Inactivation Kits Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Viral Inactivation Kits Revenue Market Share by Region (2020-2031)
 Figure 34. China Viral Inactivation Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Viral Inactivation Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Viral Inactivation Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Viral Inactivation Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Viral Inactivation Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Viral Inactivation Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Viral Inactivation Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Viral Inactivation Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Viral Inactivation Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Viral Inactivation Kits Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Viral Inactivation Kits Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Viral Inactivation Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Viral Inactivation Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Viral Inactivation Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Viral Inactivation Kits Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Viral Inactivation Kits Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Viral Inactivation Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Viral Inactivation Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Viral Inactivation Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Viral Inactivation Kits by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Viral Inactivation Kits by Type (2020-2031)
 Figure 55. Global Viral Inactivation Kits Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Viral Inactivation Kits by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Viral Inactivation Kits by Application (2020-2031)
 Figure 58. Global Viral Inactivation Kits Price (US$/Unit) by Application (2020-2031)
 Figure 59. Viral Inactivation Kits Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart